ORIGINAL RESEARCH
Published on 06 Apr 2022
Application Effect of ICG Fluorescence Real-Time Imaging Technology in Laparoscopic Hepatectomy
doi 10.3389/fonc.2022.819960
- 2,529 views
- 23 citations
- Frontiers in Oncology
- Surgical Oncology
- Research Topics
- The Landscape of Comprehensive Therapy Based on Systemic Therapy for Unresectable Hepatocellular Carcinoma (uHCC) in China
The Landscape of Comprehensive Therapy Based on Systemic Therapy for Unresectable Hepatocellular Carcinoma (uHCC) in China
19k
Total downloads
52k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 21 Mar 2022
Effects of Stereotactic Body Radiation Therapy Plus PD-1 Inhibitors for Patients With Transarterial Chemoembolization Refractory
doi 10.3389/fonc.2022.839605
- 2,596 views
- 21 citations
ORIGINAL RESEARCH
Published on 24 Feb 2022
Lenvatinib Plus Camrelizumab vs. Lenvatinib Monotherapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study
doi 10.3389/fonc.2022.809709
- 2,833 views
- 32 citations
ORIGINAL RESEARCH
Published on 17 Feb 2022
Early Alpha-Fetoprotein Response Is Associated With Survival in Patients With HBV-Related Hepatocellular Carcinoma Receiving Lenvatinib
doi 10.3389/fonc.2022.807189
- 2,469 views
- 16 citations
ORIGINAL RESEARCH
Published on 20 Dec 2021
The Efficacy of TACE Combined With Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
doi 10.3389/fonc.2021.783480
- 3,667 views
- 80 citations
CLINICAL TRIAL
Published on 24 Nov 2021
Lenvatinib Plus PD-1 Inhibitors as First-Line Treatment in Patients With Unresectable Biliary Tract Cancer: A Single-Arm, Open-Label, Phase II Study
doi 10.3389/fonc.2021.751391
- 5,756 views
- 63 citations
ORIGINAL RESEARCH
Published on 19 Nov 2021
Downstaging Therapies for Unresectable Hepatocellular Carcinoma Prior to Hepatic Resection: A Systematic Review and Meta-Analysis
doi 10.3389/fonc.2021.740762
- 4,432 views
- 20 citations
REVIEW
Published on 18 Nov 2021
Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview
doi 10.3389/fonc.2021.772195
- 5,864 views
- 48 citations
ORIGINAL RESEARCH
Published on 16 Nov 2021
Lenvatinib Plus Immune Checkpoint Inhibitors Improve Survival in Advanced Hepatocellular Carcinoma: A Retrospective Study
doi 10.3389/fonc.2021.751159
- 3,236 views
- 29 citations
ORIGINAL RESEARCH
Published on 12 Nov 2021
Surgical Conversion for Initially Unresectable Locally Advanced Hepatocellular Carcinoma Using a Triple Combination of Angiogenesis Inhibitors, Anti-PD-1 Antibodies, and Hepatic Arterial Infusion Chemotherapy: A Retrospective Study
doi 10.3389/fonc.2021.729764
- 3,907 views
- 63 citations
ORIGINAL RESEARCH
Published on 11 Nov 2021
Elevated DNA Polymerase Delta 1 Expression Correlates With Tumor Progression and Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma
doi 10.3389/fonc.2021.736363
- 2,377 views
- 9 citations
Published in
Frontiers in Oncology
Surgical Oncology
Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Participating Journals
Frontiers in Surgery
- 1.8 impact factor
- 3.3 citescore